| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |